| Sigrid CarlssonAffiliation: Lund University Country: Sweden Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised studySigrid Carlsson Department of Urology, Sahlgrenska University Hospital, Bruna stråket 11 B, SE 413 45 Goteborg, Sweden Eur J Cancer 43:2109-16. 2007 The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Göteborg randomised population-based prostate cancer screening trialSigrid Carlsson Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Bruna Straåket 11B, Goteborg, Sweden Eur J Cancer 47:545-53. 2011 Mortality results from the Göteborg randomised population-based prostate-cancer screening trialJonas Hugosson Department of Urology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Göteborg, Sweden Lancet Oncol 11:725-32. 2010 The absence of voiding symptoms in men with a prostate-specific antigen (PSA) concentration of ≥3.0 ng/mL is an independent risk factor for prostate cancer: results from the Gothenburg Randomized Screening TrialMaria Frånlund Department of Urology, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden BJU Int 110:638-43. 2012 Nationwide population-based study on 30-day mortality after radical prostatectomy in SwedenSigrid Carlsson Department of Urology, Sahlgrenska University Hospital, Gothenburg, Sweden Scand J Urol Nephrol 43:350-6. 2009
| |